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C4BP runs damage control
 
The complement inhibitor C4b-binding protein (C4BP) prevents 
necrotic cells from spilling their pro-inflammatory guts, 
according to a study on page 1937. Trouw and colleagues now 
show that C4BP and its binding partner, anticoagulant protein S 
(PS), cooperate to grab onto necrotic cells and to inhibit the 
release of cellular DNA.
C4BP short-circuits the complement cascade by binding to 
the activated complement components C3b and C4b and 
presenting them to the proteolytic complement inhibitor 
Factor I for degradation. This inhibitory capacity of C4BP can 
be coopted by bacterial pathogens, which coat themselves 
with this protein to avoid complement-mediated destruction 
by phagocytic cells.
This group recently identified a role for the C4BP–PS 
complex: it binds to apoptotic cells through the 
phosphatidylserine-binding domain of PS. This association 
could prevent the deposition and activation of complement on 
the surface of the apoptotic cells, allowing the dying cells to 
be removed without provoking an inflammatory response.
Trouw et al. now show that C4BP-PS complexes bind to 
necrotic cells in the same manner. This binding limited 
complement deposition and decreased the capacity of necrotic 
cells to induce inflammatory cytokine production by 
 
Deadly stowaway
 
A bacteriophage hitchhiker may turn a
harmless bacterium into a meningitis-
causing menace, according to Bille and
colleagues on page  1905. 
 
Neisseria
meningitidis
 
—a frequent resident of the
human upper respiratory tract—may
become a killer if it contains this phage
integrated into its chromosome.
 
N. meningitidis
 
 is usually a commensal
bacterium that lives in the upper respira-
tory tract, most often without incident.
However, certain “hyperinvasive” strains
of 
 
N. meningitidis
 
 can occasionally invade
the blood stream and cross the blood–
brain barrier, triggering outbreaks of life-
threatening meningitis. Several bacterial
An eight-kilobase genetic island encodes an integrated bacteriophage that is associated with disease in hyperinvasive strains of N. meningitidis.
 
factors are required for bacterial virulence,
including the polysaccharides that form
the bacterial capsule and the type IV
pilus adhesin protein. But these struc-
tures are widely distributed among
meningococcal strains, including those
that do not cause illness, suggesting
that other factors are also important in
causing disease.
In search of elements that might confer
pathogenicity, Bille et al. analyzed 29
hyperinvasive and 20 noninvasive 
 
N.
meningitidis
 
 isolates using a gene array.
This revealed an eight kilobase genetic
island present in 100% of hyperinvasive
isolates and absent from 90% of non-
invasive isolates. This island looked and
acted like an integrated bacteriophage,
existing independently as a double-stranded
form in the cytoplasm and being released
into the bacterial supernatant as a nuclease-
resistant (presumably encapsidated) single-
stranded circular form.
The association of the phage-like
element with disease was confirmed
when the authors analyzed isolates from a
previous epidemiologic study and found
that those containing the phage were
more likely to have caused disease. How
the phage renders 
 
N. meningitidis
 
 patho-
genic remains a matter of speculation.
One possibility, suggest the authors, is
that the phage favors bacterial invasion
into bloodstream, either by altering
bacterial gene expression or manipulating
the host immune system.
 
macrophages. Once bound to necrotic cells via PS, C4BP could 
bind and trap cellular DNA as it leaked out of the dying cells. 
The authors suggest that this function of C4BP may be critical 
for host protection from autoimmunity, as free DNA can 
trigger inflammation and elicit the production of anti-DNA 
antibodies.
The complement inhibitory protein C4b-binding protein (brown) 
binds to necrotic cells and limits the release of cellular DNA.
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Lymphocytes that can’t let go
 
On page 1987, Semmrich and colleagues
T cells that express a constitutively activated 
form of the integrin LFA-1 (bottom) have 
restricted mobility compared to those 
expressing wild-type LFA-1 (top).
 
show that immune cells expressing a
perpetually activated form of the inte-
grin LFA-1 get traction at the front of
the cell, but get stuck from behind.
Their lagging ends prevent them from
crawling through the endothelium and
initiating a normal immune response.
Integrins, such as LFA-1, are ad-
hesive molecules that switch between
active and inactive conformations and
control migration of circulating immune
cells to sites of infection and inflam-
mation. LFA-1 is also required for the
formation of stable interactions between
T cells and antigen presenting cells
(APCs). Previous studies had shown that
both tumor-specific T cell responses and
neutrophil migration are compromised in
the absence of this integrin.
The importance of LFA-1 deacti-
vation, however, has been less clear.
In vitro studies have shown that locking
LFA-1 in its activated conformation
impairs both neutrophil chemotaxis
and T cell activation. Semmrich et al.
now confirm these findings in vivo,
and show that lymphocytes from
 
Indecisive interleukin-4?
 
A study on page 1899 may explain the seemingly fickle ways 
of the cytokine interleukin (IL)-4. Yao and colleagues show 
how this quintessential T helper (Th) 2 cytokine can sometimes 
promote the opposite Th1 response.
The prototypic Th2 cytokine IL-4 inhibits IL-10 production by DCs, 
thereby increasing the production of the Th1-promoting cytokine IL-12.
 
mice  expressing a constitutively ac-
tive LFA-1 moved more slowly than
wild-type cells and failed to migrate
across endothelial cell monolayers.
Video microscopy revealed that these
defective movements were due to an
inability of the cells to release their
trailing edges.
CD4
 
 
 
 T cell proliferation and anti-
body production were also impaired in
these mice. The development of antigen-
specific CD8
 
 
 
 cytotoxic T cells, by
contrast, was not altered by the mutated
LFA-1, but the ability of these cells to
lyse  target cells was decreased. The
authors suggest that defects in T cell
activation and function may reflect
the need for serial engagement of
T cell receptors with peptide–MHC
complexes on APCs, a process that
may be compromised by the inability
to inactivate LFA-1 and thus to terminate
cell–cell contacts.
Mice expressing the mutant LFA-1
closely resembled mice lacking the
protein completely, suggesting that,
for immune cells, letting go is just as
important as grabbing on.
 
IL-4 is known as the key cytokine for polarizing naive T 
cells toward a Th2 phenotype, which is important for antibody 
production and protection against parasitic infections. Under 
some conditions, however, IL-4 has been shown to instead 
induce a Th1 response. Indeed, a recent study showed that mice 
treated with IL-4 during initial infection with 
 
Leishmania major
 
 
had increased Th1 responses and were protected. If given later, 
IL-4 increased Th2 responses and exacerbated disease.
Yao et al. now suggest that the regulation of another 
cytokine—IL-10—may explain these perplexing observations. They 
show that dendritic cells (DCs) stimulated in the presence of IL-4 
made less IL-10 than those stimulated without IL-4. As a result, 
the IL-4–treated DCs produced more of the Th1-polarizing 
cytokine IL-12—known to be inhibited by IL-10—and polarized 
naive T cells toward a Th1 phenotype more effectively. IL-10 was 
critical for the increased Th1 response, as IL-4 did not increase IL-12 
production or T cell polarization by IL-10–deficient DCs.
IL-4 had the opposite effect on B cells, provoking increased 
IL-10 production. The authors suggest that the differential 
effect of IL-4 at different times during infection may reflect a 
switch from DCs to B cells as the predominant cell type that is 
presenting antigen.
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